Literature DB >> 17129176

Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.

Dorit Naot1, Usha Bava, Brya Matthews, Karen E Callon, Gregory D Gamble, Michael Black, Sarah Song, Rocco P Pitto, Tim Cundy, Jill Cornish, Ian R Reid.   

Abstract

UNLABELLED: Paget's disease is a focal condition of bone. To study changes in cells within pagetic lesions, we cultured osteoblasts and stromal cells from 22 patients and compared gene expression in these cells to cells from healthy bone. We identified several differentially regulated genes, and we suggest that these changes could lead to the formation of the lesions.
INTRODUCTION: Paget's disease is a focal condition of bone of unknown cause. Although it is regarded as primarily an osteoclast disorder, the tight coupling of the activity of osteoclasts and osteoblasts suggests that the osteoblast could play a key role in its pathogenesis. The aim of the study was to identify possible changes in pagetic osteoblasts and stromal cells that might contribute to the development of pagetic lesions.
MATERIALS AND METHODS: Candidate genes were identified based on known bone cell regulators, supplemented with microarray analysis. Gene expression was determined by real-time PCR in primary cultures of osteoblasts and bone marrow stromal cells from pagetic patients and control subjects. Concentrations of secreted proteins were determined by ELISA.
RESULTS: Dickkopf1 mRNA and protein levels were increased in both pagetic osteoblast and stromal cell cultures, and interleukin (IL)-1 and IL-6 were overexpressed in pagetic osteoblasts. These changes parallel recent findings in myeloma bone disease, which shares some clinical similarities with Paget's disease. Alkaline phosphatase was overexpressed, and bone sialoprotein and osteocalcin were underexpressed in pagetic osteoblasts, consistent with their circulating levels in pagetic patients. It is hypothesized that overexpression of Dickkopf1, IL-1, and IL-6 would result in stimulation of osteoclast proliferation and inhibition of osteoblast growth, leading to the development of the characteristic lytic bone lesions. By stimulating osteoblast differentiation, Dickkopf1 and IL-6 may also promote mineralization, leading to the conversion of lytic lesions to sclerotic.
CONCLUSIONS: These findings suggest that dysregulated gene expression in pagetic osteoblasts could cause the changes in bone cell number and function characteristic of Paget's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17129176     DOI: 10.1359/jbmr.061108

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

Review 1.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Paget's disease: epidemiology and pathophysiology.

Authors:  Margaret Seton
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

3.  Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.

Authors:  Jumpei Teramachi; Hua Zhou; Mark A Subler; Yukiko Kitagawa; Deborah L Galson; David W Dempster; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

Review 4.  Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.

Authors:  Giacomina Brunetti; Flaviana Marzano; Silvia Colucci; Annamaria Ventura; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

Review 5.  Emerging strategies and therapies for treatment of Paget's disease of bone.

Authors:  Laëtitia Michou; Jacques P Brown
Journal:  Drug Des Devel Ther       Date:  2011-04-26       Impact factor: 4.162

6.  Gene expression profile in osteoclasts from patients with Paget's disease of bone.

Authors:  Laetitia Michou; Estelle Chamoux; Julie Couture; Jean Morissette; Jacques P Brown; Sophie Roux
Journal:  Bone       Date:  2009-11-17       Impact factor: 4.398

7.  The LIM protein LIMD1 influences osteoblast differentiation and function.

Authors:  Hilary F Luderer; Shuting Bai; Gregory D Longmore
Journal:  Exp Cell Res       Date:  2008-06-09       Impact factor: 3.905

8.  FGF-2 stimulation of RANK ligand expression in Paget's disease of bone.

Authors:  Kumaran Sundaram; Joseph Senn; Sambandam Yuvaraj; D Sudhaker Rao; Sakamuri V Reddy
Journal:  Mol Endocrinol       Date:  2009-06-25

9.  Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro.

Authors:  Jessica L Costa; Dorit Naot; Jian-Ming Lin; Maureen Watson; Karen E Callon; Ian R Reid; Andrew B Grey; Jillian Cornish
Journal:  Int J Pept       Date:  2011-09-08

Review 10.  Genetics of Paget's disease of bone.

Authors:  Stuart H Ralston; Omar M E Albagha
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.